Quarterly report pursuant to Section 13 or 15(d)

Summary of Significant Accounting Policies - Schedule of Common Stock Equivalents Excluded from the Calculation of Diluted Net Loss Per Share (Details)

v3.20.2
Summary of Significant Accounting Policies - Schedule of Common Stock Equivalents Excluded from the Calculation of Diluted Net Loss Per Share (Details) - shares
9 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Anti-dilutive securities    
Total shares excluded from diluted net loss per share applicable to common stockholders 9,389,565 8,544,035
Stock options    
Anti-dilutive securities    
Total shares excluded from diluted net loss per share applicable to common stockholders 5,549,290 4,651,250
Unvested Restricted Stock Units    
Anti-dilutive securities    
Total shares excluded from diluted net loss per share applicable to common stockholders 1,694,633 1,108,691
Warrants    
Anti-dilutive securities    
Total shares excluded from diluted net loss per share applicable to common stockholders 2,145,642 2,118,094
Convertible Preferred Stock    
Anti-dilutive securities    
Total shares excluded from diluted net loss per share applicable to common stockholders   666,000